Combined Src/SHP‐2 inhibition resulted in a supra‐additive loss of phosphorylation of Akt and ERK‐1/2, and led to an increase in apoptotic marker expression in L3.6pl and PANC‐1 pancreatic cancer cells. Here, SRC is linked to pancreatic neoplasm.